EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

A selective inhibitor reveals roles for LONP1 in mitochondrial proteostasis and OXPHOS dependencies

Zsolt Szilagyi, Pauline Michon, Carlos Pardo-Hernández iD, Mãdãlina Sãcultanu iD, Javier Miralles Fusté, Andrew M Griffin, Paul S Charifson, Cindy Phan, Yonghong Shi, Gunther Kern, Gabriel Martinez Botella, Thomas A Keating and 5 more

Life Science Alliance · 2026

DOI: 10.26508/lsa.202503535 ↗

At a glance

Journal article in Life Science Alliance, 2026. Written by Zsolt Szilagyi and 16 co-authors. Institution: Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden. Major MEDLINE topics: Mitochondria, ATP-Dependent Proteases, Mitochondrial Proteins, Proteostasis. Cited 2 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: Vetenskapsrådet, Cancerfonden, Knut och Alice Wallenbergs Stiftelse.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Lon protease 1 (LONP1) is a conserved hexameric protease implicated in mitochondrial disorders and cancer progression. In this study, we present PZL-26, a potent and selective small-molecule inhibitor that targets LONP1 without affecting the proteasome, leading to selective accumulation of mitochondrial proteins. Using PZL-26 in a whole-genome CRISPR-Cas9 screen, we identified genes essential for cell survival under protease inhibition, supporting a role for LONP1 in key mitochondrial processes, including complex I biogenesis, mitochondrial transcription, and translation. Our CRISPR screen results are consistent with proteomics analysis, with both approaches converging on the same mitochondrial pathways and highlighting functional interactions between LONP1 and other mitochondrial proteases, including potential compensatory mechanisms. These findings establish PZL-26 as an effective tool for exploring LONP1 function and pave the way for future therapeutic strategies targeting LONP1 in mitochondrial diseases and cancer.

Subjects

MeSH terms (MEDLINE)

MitochondriaATP-Dependent ProteasesMitochondrial ProteinsProteostasisOxidative PhosphorylationHumansCRISPR-Cas SystemsAnimalsProteomics

Substances

ATP-Dependent ProteasesMitochondrial ProteinsLONP1 protein, human

Authors and institutions

  • Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden.
  • Division of Molecular Metabolism, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Pretzel Therapeutics, Mölndal, Sweden.
  • Pretzel Therapeutics, Waltham, MA, USA.
  • Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden maria.falkenberg@medkem.gu.se.
  • Pretzel Therapeutics, Waltham, MA, USA jgreen@pretzeltx.com.

ORCID profiles: Carlos Pardo-Hernández, Mãdãlina Sãcultanu, Bertil Macao, Nils-Göran Larsson, Maria Falkenberg, Jeremy Green, Claes M Gustafsson

Funding

  • Vetenskapsrådet
  • Cancerfonden
  • Knut och Alice Wallenbergs Stiftelse
  • EC | European Research Council
  • Novo Nordisk Fonden
  • Västra Götalandsregionen
  • Swedish Brain Foundation
  • Swedish Diabetes Foundation

Cite

APA

Szilagyi, Z., Michon, P., Pardo-Hernández, C., Sãcultanu, M., Miralles Fusté, J., Griffin, A. M., Charifson, P. S., Phan, C., Shi, Y., Kern, G., Martinez Botella, G., Keating, T. A., Macao, B., Larsson, N. G., Falkenberg, M., Green, J., & Gustafsson, C. M. (2026). A selective inhibitor reveals roles for LONP1 in mitochondrial proteostasis and OXPHOS dependencies. Life Science Alliance. https://doi.org/10.26508/lsa.202503535

Vancouver

Szilagyi Z, Michon P, Pardo-Hernández C, Sãcultanu M, Miralles Fusté J, Griffin AM, et al. A selective inhibitor reveals roles for LONP1 in mitochondrial proteostasis and OXPHOS dependencies. Life Science Alliance. 2026. doi:10.26508/lsa.202503535

BibTeX
@article{Szilagyi2026,
  author = {Szilagyi, Zsolt and Michon, Pauline and Pardo-Hernández, Carlos and Sãcultanu, Mãdãlina and Miralles Fusté, Javier and Griffin, Andrew M and Charifson, Paul S and Phan, Cindy and Shi, Yonghong and Kern, Gunther and Martinez Botella, Gabriel and Keating, Thomas A and Macao, Bertil and Larsson, Nils-Göran and Falkenberg, Maria and Green, Jeremy and Gustafsson, Claes M},
  title = {A selective inhibitor reveals roles for LONP1 in mitochondrial proteostasis and OXPHOS dependencies},
  journal = {Life Science Alliance},
  year = {2026},
  doi = {10.26508/lsa.202503535}
}
Start for free →